Icon ICLR
NASDAQ ICLR
$169.68 -4.26 (-2.45%)
At close: Sep 17, 2026 · 4:00 PM EDT

Icon (ICLR) Asset Writedowns and Impairment (2021 - 2025)

Icon's (ICLR) quarterly Asset Writedowns and Impairment came in at -$64.3 million in Q4 2025, down 508.58% year-over-year from $15.7 million in Q4 2024, and down 508.58% quarter-over-quarter from $15.7 million in Q4 2024.

Analysis

Icon (ICLR) Asset Writedowns and Impairment (2021 - 2025) Analysis & Trends

Icon (ICLR) has reported Asset Writedowns and Impairment for 5 consecutive years, with -$64.3 million the latest figure, recorded in Q4 2025.

  • On a quarterly basis, Asset Writedowns and Impairment fell 508.58% year-over-year to -$64.3 million in Q4 2025; TTM through Dec 2025 was -$48.5 million, a 804.94% decrease from a year earlier, with the FY2025 full-year figure at $101.0 million, up 542.22% from the prior year.
  • Asset Writedowns and Impairment was -$64.3 million for Q4 2025 at Icon, down from $15.7 million in the prior quarter.
  • Over five years, Asset Writedowns and Impairment peaked at $17.2 million in Q2 2022 and troughed at -$64.3 million in Q4 2025.
  • A 5-year average of $20153.8 and a median of $3.6 million in 2022 frame the typical range for Asset Writedowns and Impairment.
  • Across the five-year window, Asset Writedowns and Impairment tumbled 950.48% in 2023 and surged 277.85% in 2024, its largest moves.
  • Over 5 years, Asset Writedowns and Impairment stood at $14.3 million in 2021, then slumped by 92.73% to $1.0 million in 2022, then plunged by 950.48% to -$8.8 million in 2023, then surged by 277.85% to $15.7 million in 2024, then tumbled by 508.58% to -$64.3 million in 2025.
  • The last three Asset Writedowns and Impairment figures came in at -$64.3 million (Q4 2025), $15.7 million (Q4 2024), and -$8.8 million (Q4 2023), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Iqvia Holdings 44.72 Bn 42.64 Bn 1.44 Bn
2 Medpace Holdings 17.37 Bn 16.87 Bn 201.64 Mn
3 Icon 13.65 Bn 12.72 Bn 479.29 Mn
4 Charles River Laboratories International 13.13 Bn 12.94 Bn 452.07 Mn
5 Fortrea Holdings 1.89 Bn 1.72 Bn 139.20 Mn
6 Evotec SE 574.75 Mn 148.87 Mn -
7 Ginkgo Bioworks Holdings 439.63 Mn 355.09 Mn 18.44 Mn
8 Champions Oncology 69.43 Mn 65.03 Mn 7.70 Mn
9 MindWalk Holdings 51.76 Mn 46.29 Mn 1.61 Mn
10 VivoSim Labs 1.37 Mn 1.37 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -64.27 Mn
Dec 31, 2024 15.73 Mn
Dec 31, 2023 -8.85 Mn
Sep 30, 2023 232,000.00
Jun 30, 2023 1.68 Mn
Mar 31, 2023 6.93 Mn
Dec 31, 2022 1.04 Mn
Sep 30, 2022 6.98 Mn
Jun 30, 2022 17.18 Mn
Mar 31, 2022 3.57 Mn
Dec 31, 2021 14.31 Mn
Sep 30, 2021 -8.70 Mn
Jun 30, 2021 14.43 Mn